Curaleaf (OTCMKTS:CURLF) Shares Gap Down – Time to Sell?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF)’s share price gapped down before the market opened on Friday. The stock had previously closed at $8.87, but opened at $8.26. Curaleaf shares last traded at $8.15, with a volume of 3,628 shares trading hands.

Analyst Ratings Changes

Several analysts have recently weighed in on the stock. Citigroup restated a “buy” rating on shares of Curaleaf in a research report on Thursday, August 6th. Zacks Research cut Curaleaf from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 13th. Finally, UBS Group set a $6.00 price objective on Curaleaf in a report on Monday, October 5th. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $6.00.

Curaleaf Price Performance

The firm has a fifty day moving average of $9.47 and a two-hundred day moving average of $8.35. The company has a current ratio of 1.61, a quick ratio of 0.78 and a debt-to-equity ratio of 1.09. The company has a market capitalization of $1.83 billion, a PE ratio of -195.75 and a beta of 1.62.

Curaleaf (OTCMKTS:CURLF) last announced its quarterly earnings data on Tuesday, November 3rd. The company reported ($0.14) earnings per share for the quarter, beating the consensus estimate of ($0.16) by $0.02. The firm had revenue of $352.65 million during the quarter, compared to the consensus estimate of $346.46 million. Curaleaf had a positive return on equity of 0.43% and a negative net margin of 0.76%. Research analysts anticipate that Curaleaf Holdings, Inc. will post 0.05 EPS for the current fiscal year.

About Curaleaf

Curaleaf Holdings, Inc. is a cannabis company that cultivates, processes and sells cannabis products for medical and adult-use markets. Its products include cannabis flower, pre-rolls, concentrates, vapes, edibles, tinctures and topical products, sold under brands including Curaleaf, Select and Grassroots. The company operates across multiple U.S. markets through cultivation and processing facilities, wholesale operations and retail dispensaries. Through Curaleaf International, it also serves medical cannabis markets in Europe and other international markets.